Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred SharesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Invesco (IVZ) Other Non-Current Liabilities (2016 - 2024)

Historic Other Non-Current Liabilities for Invesco (IVZ) over the last 16 years, with Q3 2024 value amounting to $484.1 million.

  • Invesco's Other Non-Current Liabilities rose 5020.17% to $484.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $484.1 million, marking a year-over-year increase of 5020.17%. This contributed to the annual value of $492.1 million for FY2023, which is 4930.22% up from last year.
  • As of Q3 2024, Invesco's Other Non-Current Liabilities stood at $484.1 million, which was up 5020.17% from $531.8 million recorded in Q2 2024.
  • In the past 5 years, Invesco's Other Non-Current Liabilities registered a high of $1.1 billion during Q2 2021, and its lowest value of $15.9 million during Q1 2020.
  • In the last 5 years, Invesco's Other Non-Current Liabilities had a median value of $459.1 million in 2024 and averaged $479.8 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first surged by 407358.49% in 2021, then plummeted by 6685.17% in 2022.
  • Quarter analysis of 5 years shows Invesco's Other Non-Current Liabilities stood at $588.6 million in 2020, then surged by 43.78% to $846.3 million in 2021, then tumbled by 61.05% to $329.6 million in 2022, then skyrocketed by 49.3% to $492.1 million in 2023, then decreased by 1.63% to $484.1 million in 2024.
  • Its last three reported values are $484.1 million in Q3 2024, $531.8 million for Q2 2024, and $459.1 million during Q1 2024.